Eli Health Closes $17-Million CAD Series A

Montreal-based healthtech innovator Eli Health has successfully closed a $17 million CAD ($12 million USD) Series A funding round, led by BDC Capital. The investment will fuel the commercial launch of Eli Health's revolutionary hormone-monitoring technology, which provides instant, at-home hormone testing results. This breakthrough technology empowers individuals to track and optimize their hormonal health with unprecedented ease and accuracy, addressing a critical gap in preventive healthcare.